Hypertensive Intracerebral Hemorrhage: Pathophysiology, Risk Factors, and Management

Pathophysiology

• Hypertensive intracerebral hemorrhage arises from arteriolosclerosis (lipohyalinosis) causing rupture of penetrating arterioles in deep brain territories such as the basal ganglia, thalamus, brainstem, and deep cerebellar nuclei. 1
• The underlying small‑vessel disease is characterized by concentric hyalinized thickening of the vascular wall of penetrating arterioles. 1

Risk Factors

• Diabetes mellitus is identified as a significant risk factor for hypertensive intracerebral hemorrhage. 1
• Advanced age is associated with an increased incidence of hypertensive intracerebral hemorrhage. 1

Common Anatomical Locations

• Hemorrhages frequently involve deep white matter and are grouped with basal ganglia, thalamus, brainstem, and deep cerebellar nuclei as “deep territories,” which are distinct from lobar locations linked to cerebral amyloid angiopathy. [1][2]

Mechanisms of Brain Injury

Direct Pressure Effects

• Local compression of adjacent brain tissue, elevated intracranial pressure, hydrocephalus, and brain herniation occur as direct consequences of the hematoma. 1
• Early hematoma expansion is a consistent predictor of poorer clinical outcomes. [1][2]

Secondary Injury Mechanisms

• Cerebral edema develops secondary to the hemorrhage. 1
• Inflammatory responses are triggered following the bleed. 1
• Blood‑derived toxic substances such as hemoglobin, iron, and thrombin contribute to biochemical toxicity. [1][2]

Clinical Implications

• Blood‑pressure reduction and reversal of anticoagulation are the primary therapeutic strategies aimed at limiting hematoma expansion, although effective neuroprotective agents have not yet been identified. [1][2]